TRex Bio, Inc. TRXB
10.00 USD -0.77 (-7.15%)
Regular-session close
10.00 0.00 0.00%
After hours · Nov 17, 4:00 PM ET
9.61 Day range 11.11
9.61 52-week range 16.56
- YTD
- -28.57%
- 1 year
- -28.57%
News
benzinga.com Trex Bio Q3 EPS $(10.06) Trex Bio (NASDAQ:TRXB) reported quarterly losses of $(10.06) per share . This is a 32.72 percent decrease over losses of $(7.58) per share from the same period last year.
globenewswire.com TRexBio Reports Third Quarter 2026 Financial Results and Recent Business Highlights Positive Phase 1a results for TRB-061 support proof of mechanism, with topline Phase 1b data in atopic dermatitis expected in mid-2027 TRB-071 advancing through IND-enabling studies, with Phase 1…benzinga.com Evercore ISI Group Initiates Coverage On Trex Bio with Outperform Rating, Announces Price Target of $28 Evercore ISI Group analyst Gavin Clark-Gartner initiates coverage on Trex Bio (NASDAQ:TRXB) with a Outperform rating and announces Price Target of $28.
benzinga.com This X-Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday New coverage: Pony AI Overweight/$10, X-Energy Outperform/$17, TRex Bio Buy/$39, NuScale Underperform/$5.benzinga.com JP Morgan Initiates Coverage On Trex Bio with Overweight Rating, Announces Price Target of $20 JP Morgan analyst Brian Cheng initiates coverage on Trex Bio (NASDAQ:TRXB) with a Overweight rating and announces Price Target of $20.
benzinga.com Stifel Initiates Coverage On Trex Bio with Buy Rating, Announces Price Target of $39 Stifel analyst Alex Thompson initiates coverage on Trex Bio (NASDAQ:TRXB) with a Buy rating and announces Price Target of $39.
benzinga.com Wedbush Initiates Coverage On Trex Bio with Outperform Rating, Announces Price Target of $30 Wedbush analyst Martin Fan initiates coverage on Trex Bio (NASDAQ:TRXB) with a Outperform rating and announces Price Target of $30.
